Playback speed
10 seconds
Nivolumab vs. Chemo in Relapsed SCLC (review of Checkmate-331 trial)
By
Beacon Medical Interchange
FEATURING
Jack West
By
Beacon Medical Interchange
FEATURING
Jack West
0 views
December 27, 2018
Dr. Jack West reviews the trial design, key results, and implications of the CheckMate-331 trial ...
read more ↘ of nivolumab (Opdivo) vs. standard chemotherapy for relapsed small cell lung cancer.
↖ read less
read more ↘ of nivolumab (Opdivo) vs. standard chemotherapy for relapsed small cell lung cancer.
↖ read less
Comments 0
Login to view comments.
Click here to Login
Lung